APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cold Chain Services for Innovative Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cold Chain Services for Innovative Drug Market Outlook and Growth Opportunities 2026

Report ID 17409604045 June 2026199 pages

Choose your research edition.

Industry ResearchCold Chain Services for Innovative Drug Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Cold Chain Services for Innovative Drug Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Cold Chain Services for Innovative Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cold Chain Services for Innovative Drug Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Cold Chain Services for Innovative Drug Market Analysis and Forecast 2026-2032240 pages · $4,950 USD

Market perspective

The global Cold Chain Services for Innovative Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cold Chain Services for Innovative Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cold Chain Services for Innovative Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cold Chain Services for Innovative Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cold Chain Services for Innovative Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cold Chain Services for Innovative Drug market include Marken, World Courier, Cryoport, DTW Logistics, City Express, Shanghai Shengsheng Pharmaceutical Cold Chain Technology, Thermo Fisher, SF Express and Catalent, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Cold Chain Services for Innovative Drug market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cold Chain Services for Innovative Drug and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cold Chain Services for Innovative Drug revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Cold Chain Services for Innovative Drug market.

Cold Chain Services for Innovative Drug Segment by Company

Marken

World Courier

Cryoport

DTW Logistics

City Express

Shanghai Shengsheng Pharmaceutical Cold Chain Technology

Thermo Fisher

SF Express

Catalent

CIMC Cold Cloud

Guoyuan Life Sciences Group

Rochin Logistics

Azenta

Saroute

Cold Chain Services for Innovative Drug Segment by Type

International Transportation

Domestic Transportation

Cold Chain Services for Innovative Drug Segment by Application

Pharmaceutical Companies

Hospitals

Laboratories

Others

Cold Chain Services for Innovative Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Cold Chain Services for Innovative Drug status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Cold Chain Services for Innovative Drug key companies, revenue, market share, and recent developments.

3. To split the Cold Chain Services for Innovative Drug breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Cold Chain Services for Innovative Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cold Chain Services for Innovative Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Cold Chain Services for Innovative Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cold Chain Services for Innovative Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cold Chain Services for Innovative Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cold Chain Services for Innovative Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cold Chain Services for Innovative Drug industry.

Chapter 3: Detailed analysis of Cold Chain Services for Innovative Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Cold Chain Services for Innovative Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Cold Chain Services for Innovative Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cold Chain Services for Innovative Drug Industry Trends Table 2. Cold Chain Services for Innovative Drug Industry Drivers Table 3. Cold Chain Services for Innovative Drug Industry Opportunities and Challenges Table 4. Cold Chain Services for Innovative Drug Industry Restraints Table 5. Global Cold Chain Services for Innovative Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cold Chain Services for Innovative Drug Revenue Share by Company (2021-2026) Table 7. Global Cold Chain Services for Innovative Drug Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Cold Chain Services for Innovative Drug Key Company Manufacturing Base & Headquarters Table 9. Global Cold Chain Services for Innovative Drug Company, Product Type & Application Table 10. Global Cold Chain Services for Innovative Drug Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Cold Chain Services for Innovative Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of International Transportation Table 15. Significant Companies of Domestic Transportation Table 16. Global Cold Chain Services for Innovative Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Cold Chain Services for Innovative Drug Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Cold Chain Services for Innovative Drug Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Cold Chain Services for Innovative Drug Sales Value Share by Type (2021-2026) Table 20. Global Cold Chain Services for Innovative Drug Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Pharmaceutical Companies Table 22. Significant Companies of Hospitals Table 23. Significant Companies of Laboratories Table 24. Significant Companies of Others Table 25. Global Cold Chain Services for Innovative Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Cold Chain Services for Innovative Drug Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Cold Chain Services for Innovative Drug Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Cold Chain Services for Innovative Drug Sales Value Share by Application (2021-2026) Table 29. Global Cold Chain Services for Innovative Drug Sales Value Share by Application (2027-2032) Table 30. Global Cold Chain Services for Innovative Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Cold Chain Services for Innovative Drug Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Cold Chain Services for Innovative Drug Sales Value Share by Region (2021-2026) Table 33. Global Cold Chain Services for Innovative Drug Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Cold Chain Services for Innovative Drug Sales Value Share by Region (2027-2032) Table 35. Global Cold Chain Services for Innovative Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Cold Chain Services for Innovative Drug Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Cold Chain Services for Innovative Drug Sales Value Market Share by Country (2021-2026) Table 38. Global Cold Chain Services for Innovative Drug Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Cold Chain Services for Innovative Drug Sales Value Market Share by Country (2027-2032) Table 40. Marken Company Information Table 41. Marken Business Overview Table 42. Marken Cold Chain Services for Innovative Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Marken Cold Chain Services for Innovative Drug Product Portfolio Table 44. Marken Recent Development Table 45. World Courier Company Information Table 46. World Courier Business Overview Table 47. World Courier Cold Chain Services for Innovative Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. World Courier Cold Chain Services for Innovative Drug Product Portfolio Table 49. World Courier Recent Development Table 50. Cryoport Company Information Table 51. Cryoport Business Overview Table 52. Cryoport Cold Chain Services for Innovative Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Cryoport Cold Chain Services for Innovative Drug Product Portfolio Table 54. Cryoport Recent Development Table 55. DTW Logistics Company Information Table 56. DTW Logistics Business Overview Table 57. DTW Logistics Cold Chain Services for Innovative Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. DTW Logistics Cold Chain Services for Innovative Drug Product Portfolio Table 59. DTW Logistics Recent Development Table 60. City Express Company Information Table 61. City Express Business Overview Table 62. City Express Cold Chain Services for Innovative Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. City Express Cold Chain Services for Innovative Drug Product Portfolio Table 64. City Express Recent Development Table 65. Shanghai Shengsheng Pharmaceutical Cold Chain Technology Company Information Table 66. Shanghai Shengsheng Pharmaceutical Cold Chain Technology Business Overview Table 67. Shanghai Shengsheng Pharmaceutical Cold Chain Technology Cold Chain Services for Innovative Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Shanghai Shengsheng Pharmaceutical Cold Chain Technology Cold Chain Services for Innovative Drug Product Portfolio Table 69. Shanghai Shengsheng Pharmaceutical Cold Chain Technology Recent Development Table 70. Thermo Fisher Company Information Table 71. Thermo Fisher Business Overview Table 72. Thermo Fisher Cold Chain Services for Innovative Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Thermo Fisher Cold Chain Services for Innovative Drug Product Portfolio Table 74. Thermo Fisher Recent Development Table 75. SF Express Company Information Table 76. SF Express Business Overview Table 77. SF Express Cold Chain Services for Innovative Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. SF Express Cold Chain Services for Innovative Drug Product Portfolio Table 79. SF Express Recent Development Table 80. Catalent Company Information Table 81. Catalent Business Overview Table 82. Catalent Cold Chain Services for Innovative Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Catalent Cold Chain Services for Innovative Drug Product Portfolio Table 84. Catalent Recent Development Table 85. CIMC Cold Cloud Company Information Table 86. CIMC Cold Cloud Business Overview Table 87. CIMC Cold Cloud Cold Chain Services for Innovative Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. CIMC Cold Cloud Cold Chain Services for Innovative Drug Product Portfolio Table 89. CIMC Cold Cloud Recent Development Table 90. Guoyuan Life Sciences Group Company Information Table 91. Guoyuan Life Sciences Group Business Overview Table 92. Guoyuan Life Sciences Group Cold Chain Services for Innovative Drug Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Guoyuan Life Sciences Group Cold Chain Services for Innovative Drug Product Portfolio Table 94. Guoyuan Life Sciences Group Recent Development Table 95. Rochin Logistics Company Information Table 96. Rochin Logistics Business Overview Table 97. Rochin Logistics Cold Chain Services for Innovative Drug Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Rochin Logistics Cold Chain Services for Innovative Drug Product Portfolio Table 99. Rochin Logistics Recent Development Table 100. Azenta Company Information Table 101. Azenta Business Overview Table 102. Azenta Cold Chain Services for Innovative Drug Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Azenta Cold Chain Services for Innovative Drug Product Portfolio Table 104. Azenta Recent Development Table 105. Saroute Company Information Table 106. Saroute Business Overview Table 107. Saroute Cold Chain Services for Innovative Drug Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Saroute Cold Chain Services for Innovative Drug Product Portfolio Table 109. Saroute Recent Development Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Cold Chain Services for Innovative Drug Product Image Figure 2. Global Cold Chain Services for Innovative Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cold Chain Services for Innovative Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Cold Chain Services for Innovative Drug Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. International Transportation Image Figure 8. Domestic Transportation Image Figure 9. Global Cold Chain Services for Innovative Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Cold Chain Services for Innovative Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Cold Chain Services for Innovative Drug Sales Value Share by Type (2021-2032) Figure 12. Pharmaceutical Companies Image Figure 13. Hospitals Image Figure 14. Laboratories Image Figure 15. Others Image Figure 16. Global Cold Chain Services for Innovative Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Cold Chain Services for Innovative Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Cold Chain Services for Innovative Drug Sales Value Share by Application (2021-2032) Figure 19. Global Cold Chain Services for Innovative Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Cold Chain Services for Innovative Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Cold Chain Services for Innovative Drug Sales Value (2021-2032) & (US$ Million) Figure 22. North America Cold Chain Services for Innovative Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Cold Chain Services for Innovative Drug Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Cold Chain Services for Innovative Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Cold Chain Services for Innovative Drug Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Cold Chain Services for Innovative Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Cold Chain Services for Innovative Drug Sales Value (2021-2032) & (US$ Million) Figure 28. South America Cold Chain Services for Innovative Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Cold Chain Services for Innovative Drug Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Cold Chain Services for Innovative Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • International Transportation
  • Domestic Transportation
Applications
  • Pharmaceutical Companies
  • Hospitals
  • Laboratories
  • Others
Companies covered
  • Marken
  • World Courier
  • Cryoport
  • DTW Logistics
  • City Express
  • Shanghai Shengsheng Pharmaceutical Cold Chain Technology
  • Thermo Fisher
  • SF Express
  • Catalent
  • CIMC Cold Cloud
  • Guoyuan Life Sciences Group
  • Rochin Logistics
  • Azenta
  • Saroute

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cold Chain Services for Innovative Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cold Chain Services for Innovative Drug Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Cold Chain Services for Innovative Drug Market Dynamics
  1. 2.1 Cold Chain Services for Innovative Drug Industry Trends
  2. 2.2 Cold Chain Services for Innovative Drug Industry Drivers
  3. 2.3 Cold Chain Services for Innovative Drug Industry Opportunities and Challenges
  4. 2.4 Cold Chain Services for Innovative Drug Industry Restraints
3 Cold Chain Services for Innovative Drug Market by Company
  1. 3.1 Global Cold Chain Services for Innovative Drug Company Revenue Ranking in 2025
  2. 3.2 Global Cold Chain Services for Innovative Drug Revenue by Company (2021-2026)
  3. 3.3 Global Cold Chain Services for Innovative Drug Company Ranking (2024-2026)
  4. 3.4 Global Cold Chain Services for Innovative Drug Company Manufacturing Base and Headquarters
  5. 3.5 Global Cold Chain Services for Innovative Drug Company Product Type and Application
  6. 3.6 Global Cold Chain Services for Innovative Drug Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Cold Chain Services for Innovative Drug Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Cold Chain Services for Innovative Drug Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Cold Chain Services for Innovative Drug Market by Type
  1. 4.1 Cold Chain Services for Innovative Drug Type Introduction
  2. 4.1.1 International Transportation
  3. 4.1.2 Domestic Transportation
  4. 4.2 Global Cold Chain Services for Innovative Drug Sales Value by Type
  5. 4.2.1 Global Cold Chain Services for Innovative Drug Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Cold Chain Services for Innovative Drug Sales Value by Type (2021-2032)
  7. 4.2.3 Global Cold Chain Services for Innovative Drug Sales Value Share by Type (2021-2032)
5 Cold Chain Services for Innovative Drug Market by Application
  1. 5.1 Cold Chain Services for Innovative Drug Application Introduction
  2. 5.1.1 Pharmaceutical Companies
  3. 5.1.2 Hospitals
  4. 5.1.3 Laboratories
  5. 5.1.4 Others
  6. 5.2 Global Cold Chain Services for Innovative Drug Sales Value by Application
  7. 5.2.1 Global Cold Chain Services for Innovative Drug Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Cold Chain Services for Innovative Drug Sales Value by Application (2021-2032)
  9. 5.2.3 Global Cold Chain Services for Innovative Drug Sales Value Share by Application (2021-2032)
6 Cold Chain Services for Innovative Drug Regional Value Analysis
  1. 6.1 Global Cold Chain Services for Innovative Drug Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cold Chain Services for Innovative Drug Sales Value by Region (2021-2032)
  3. 6.2.1 Global Cold Chain Services for Innovative Drug Sales Value by Region: 2021-2026
  4. 6.2.2 Global Cold Chain Services for Innovative Drug Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cold Chain Services for Innovative Drug Sales Value (2021-2032)
  7. 6.3.2 North America Cold Chain Services for Innovative Drug Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Cold Chain Services for Innovative Drug Sales Value (2021-2032)
  10. 6.4.2 Europe Cold Chain Services for Innovative Drug Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Cold Chain Services for Innovative Drug Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Cold Chain Services for Innovative Drug Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Cold Chain Services for Innovative Drug Sales Value (2021-2032)
  16. 6.6.2 South America Cold Chain Services for Innovative Drug Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Cold Chain Services for Innovative Drug Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Cold Chain Services for Innovative Drug Sales Value Share by Country, 2025 VS 2032
7 Cold Chain Services for Innovative Drug Country-level Value Analysis
  1. 7.1 Global Cold Chain Services for Innovative Drug Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cold Chain Services for Innovative Drug Sales Value by Country (2021-2032)
  3. 7.2.1 Global Cold Chain Services for Innovative Drug Sales Value by Country (2021-2026)
  4. 7.2.2 Global Cold Chain Services for Innovative Drug Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Cold Chain Services for Innovative Drug Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Cold Chain Services for Innovative Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Cold Chain Services for Innovative Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Marken
  2. 8.1.1 Marken Company Information
  3. 8.1.2 Marken Business Overview
  4. 8.1.3 Marken Cold Chain Services for Innovative Drug Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Marken Cold Chain Services for Innovative Drug Product Portfolio
  6. 8.1.5 Marken Recent Developments
  7. 8.2 World Courier
  8. 8.2.1 World Courier Company Information
  9. 8.2.2 World Courier Business Overview
  10. 8.2.3 World Courier Cold Chain Services for Innovative Drug Revenue and Gross Margin (2021-2026)
  11. 8.2.4 World Courier Cold Chain Services for Innovative Drug Product Portfolio
  12. 8.2.5 World Courier Recent Developments
  13. 8.3 Cryoport
  14. 8.3.1 Cryoport Company Information
  15. 8.3.2 Cryoport Business Overview
  16. 8.3.3 Cryoport Cold Chain Services for Innovative Drug Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cryoport Cold Chain Services for Innovative Drug Product Portfolio
  18. 8.3.5 Cryoport Recent Developments
  19. 8.4 DTW Logistics
  20. 8.4.1 DTW Logistics Company Information
  21. 8.4.2 DTW Logistics Business Overview
  22. 8.4.3 DTW Logistics Cold Chain Services for Innovative Drug Revenue and Gross Margin (2021-2026)
  23. 8.4.4 DTW Logistics Cold Chain Services for Innovative Drug Product Portfolio
  24. 8.4.5 DTW Logistics Recent Developments
  25. 8.5 City Express
  26. 8.5.1 City Express Company Information
  27. 8.5.2 City Express Business Overview
  28. 8.5.3 City Express Cold Chain Services for Innovative Drug Revenue and Gross Margin (2021-2026)
  29. 8.5.4 City Express Cold Chain Services for Innovative Drug Product Portfolio
  30. 8.5.5 City Express Recent Developments
  31. 8.6 Shanghai Shengsheng Pharmaceutical Cold Chain Technology
  32. 8.6.1 Shanghai Shengsheng Pharmaceutical Cold Chain Technology Company Information
  33. 8.6.2 Shanghai Shengsheng Pharmaceutical Cold Chain Technology Business Overview
  34. 8.6.3 Shanghai Shengsheng Pharmaceutical Cold Chain Technology Cold Chain Services for Innovative Drug Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shanghai Shengsheng Pharmaceutical Cold Chain Technology Cold Chain Services for Innovative Drug Product Portfolio
  36. 8.6.5 Shanghai Shengsheng Pharmaceutical Cold Chain Technology Recent Developments
  37. 8.7 Thermo Fisher
  38. 8.7.1 Thermo Fisher Company Information
  39. 8.7.2 Thermo Fisher Business Overview
  40. 8.7.3 Thermo Fisher Cold Chain Services for Innovative Drug Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Thermo Fisher Cold Chain Services for Innovative Drug Product Portfolio
  42. 8.7.5 Thermo Fisher Recent Developments
  43. 8.8 SF Express
  44. 8.8.1 SF Express Company Information
  45. 8.8.2 SF Express Business Overview
  46. 8.8.3 SF Express Cold Chain Services for Innovative Drug Revenue and Gross Margin (2021-2026)
  47. 8.8.4 SF Express Cold Chain Services for Innovative Drug Product Portfolio
  48. 8.8.5 SF Express Recent Developments
  49. 8.9 Catalent
  50. 8.9.1 Catalent Company Information
  51. 8.9.2 Catalent Business Overview
  52. 8.9.3 Catalent Cold Chain Services for Innovative Drug Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Catalent Cold Chain Services for Innovative Drug Product Portfolio
  54. 8.9.5 Catalent Recent Developments
  55. 8.10 CIMC Cold Cloud
  56. 8.10.1 CIMC Cold Cloud Company Information
  57. 8.10.2 CIMC Cold Cloud Business Overview
  58. 8.10.3 CIMC Cold Cloud Cold Chain Services for Innovative Drug Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CIMC Cold Cloud Cold Chain Services for Innovative Drug Product Portfolio
  60. 8.10.5 CIMC Cold Cloud Recent Developments
  61. 8.11 Guoyuan Life Sciences Group
  62. 8.11.1 Guoyuan Life Sciences Group Company Information
  63. 8.11.2 Guoyuan Life Sciences Group Business Overview
  64. 8.11.3 Guoyuan Life Sciences Group Cold Chain Services for Innovative Drug Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Guoyuan Life Sciences Group Cold Chain Services for Innovative Drug Product Portfolio
  66. 8.11.5 Guoyuan Life Sciences Group Recent Developments
  67. 8.12 Rochin Logistics
  68. 8.12.1 Rochin Logistics Company Information
  69. 8.12.2 Rochin Logistics Business Overview
  70. 8.12.3 Rochin Logistics Cold Chain Services for Innovative Drug Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Rochin Logistics Cold Chain Services for Innovative Drug Product Portfolio
  72. 8.12.5 Rochin Logistics Recent Developments
  73. 8.13 Azenta
  74. 8.13.1 Azenta Company Information
  75. 8.13.2 Azenta Business Overview
  76. 8.13.3 Azenta Cold Chain Services for Innovative Drug Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Azenta Cold Chain Services for Innovative Drug Product Portfolio
  78. 8.13.5 Azenta Recent Developments
  79. 8.14 Saroute
  80. 8.14.1 Saroute Company Information
  81. 8.14.2 Saroute Business Overview
  82. 8.14.3 Saroute Cold Chain Services for Innovative Drug Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Saroute Cold Chain Services for Innovative Drug Product Portfolio
  84. 8.14.5 Saroute Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst